search
Back to results

Continuous Compressions With Asynchronous Ventilations Using I-gel Device Versus 30:2 Approach During Simulated OHCA

Primary Purpose

Cardiac Arrest, Cardiopulmonary Arrest, Emergency Medical Services

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
I-gel® supraglottic device
Face mask ventilation
Sponsored by
Geneve TEAM Ambulances
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiac Arrest

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • To be a registered paramedic or EMT
  • To have previously completed the 20-minute workshop on how using the device by on of the study investigators
  • To have previously completed the 20-minute self-training session following a video recorded by the study investigators
  • Participation agreement

Exclusion Criteria:

  • Member of the study investigators
  • To have not undergone the 20-minute workshop
  • To have not watch the video

Sites / Locations

  • Genève TEAM Ambulances

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

I-gel® group

Standard group

Arm Description

Continuous chest compressions from the start of the CPR with early i-gel® device insertion and asynchronous ventilations

Basic (standard) management by using a ratio of 30 compressions and 2 face mask ventilations

Outcomes

Primary Outcome Measures

Chest compressions fraction (CCF) over the first 2 minutes of CPR
Proportion of time where compressions are performed during the first two minutes of the scenario

Secondary Outcome Measures

CCF of second cycle
Proportion of time where compressions are performed during the following two minutes of the scenario
CCF of third cycle
Proportion of time where compressions are performed during the following two minutes of the scenario
CCF of fourth cycle
Proportion of time where compressions are performed during the following two minutes of the scenario
CCF of fifth cycle
Proportion of time where compressions are performed during the following two minutes of the scenario
Overall CCF
Proportion of time where compressions are performed during the entire scenario
Chest compressions depth
Mean depth of compressions
Proportions of compressions above, below and in the depth target
The depth target is 5 to 6 cm
Chest compressions frequency
Mean frequency of compressions
Proportions of compressions above, below and in the frequency target
The frequency target is 100 to 120 compressions by minute
Time to first shock
Interval between start of compressions and delivering of first shock
Time to first effective ventilation
Interval between start of compressions and delivering of first effective ventilation (defined as volume >300 ml)
Ventilations volume
Mean volume of ventilations
Proportions of ventilations above, below and in the volume target
The volume target is 300 to 700 ml
User satisfaction assessed by a 5-point Likert scale ranging from "Not satisfied" to "Very satisfied"
User satisfaction regarding applied approach assessed on a 5-point Likert scale ranging from "Not satisfied" to "Very satisfied"
Self-assessed cognitive load using a 9-point scale ranging from "Very, very low mentale effort" to "Very, very high mental effort"
Self-reported cognitive load during resuscitation scenario assessed using a 9-point symmetrical category scale which ranged from "Very, very low mental effort" (1) to "Very, very high mental effort" (9),
Chest compression relaxation
Proportion of correct compressions (with less than 5 mm deviation from reference value)
Number of delivered ventilations
Absolute number of delivered ventilations

Full Information

First Posted
January 8, 2021
Last Updated
January 8, 2023
Sponsor
Geneve TEAM Ambulances
Collaborators
Service de protection et sauvetage Lausanne (SPSL), Emergency Medical Services, Switzerland, Ambulance Riviera, Emergency Medical Services, La Tour-de-Peilz, Switzerland, Compagnie d'Ambulances de l'Hôpital du Valais, Emergency Medical Services, Martigny, Switzerland, Swissrescue.ch, Website for Prehospital Healthcare Providers, Les Pontins, Switzerland, ESAMB - College of Higher Education in Ambulance Care, Geneva, Switzerland, STAR Ambulances, Emergency Medical Services, Épalinges, Vaud
search

1. Study Identification

Unique Protocol Identification Number
NCT04736446
Brief Title
Continuous Compressions With Asynchronous Ventilations Using I-gel Device Versus 30:2 Approach During Simulated OHCA
Official Title
Continuous Manual Chest Compressions With Asynchronous Ventilations Using the I-gel Device Versus 30:2 Current Practice Approach With Face Mask Ventilations During Simulated OHCA: Manikin Multicentre Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
February 14, 2021 (Actual)
Primary Completion Date
May 18, 2021 (Actual)
Study Completion Date
May 18, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Geneve TEAM Ambulances
Collaborators
Service de protection et sauvetage Lausanne (SPSL), Emergency Medical Services, Switzerland, Ambulance Riviera, Emergency Medical Services, La Tour-de-Peilz, Switzerland, Compagnie d'Ambulances de l'Hôpital du Valais, Emergency Medical Services, Martigny, Switzerland, Swissrescue.ch, Website for Prehospital Healthcare Providers, Les Pontins, Switzerland, ESAMB - College of Higher Education in Ambulance Care, Geneva, Switzerland, STAR Ambulances, Emergency Medical Services, Épalinges, Vaud

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Paramedics and EMT will be recruited among four Emergency Medical Services (EMS) in Switzerland to manage a 10-minutes simulation-based adult out-of-hospital cardiac arrest scenario in teams of two. Depending on randomization, each team will manage the scenario according either to their current approach (30 compressions with 2 bag-mask ventilations), or to the experimental approach (continuous compressions since the start of CPR except for rhythm analysis and shock delivering, with early insertion of an i-gel® device to deliver asynchronous ventilations). The main hypothesis is that early insertion of i-gel could improve CCF during out-of-hospital cardiac arrest, with a reasonable time to first effective ventilation.
Detailed Description
Pre-scenario standardized workshop: First, information about the study will be given and participants' questions are answered. Written consent will be obtained and the first part of the questionnaire individually completed. Participants will be told that the resuscitation scenario will be stopped after 10 minutes, independently of their actions and that no feedback will be given. Then, the use of i-gel® device use will be taught by one of the investigators (LSt) in accordance with Peyton's approach because this approach has shown superiority, and based on a standard operating procedure created by study investigators following manufacturer's instructions: The instructor performs a complete insertion sequence in real-time without any comments; The instructor performs an insertion sequence with step-by-step explanations (description of key points); The learners guide the instructor step by step to perform the insertion; The learners do the complete insertion sequence then feedback could be given. They will perform this step a maximum of 3 times. This workshop will last 20 minutes. Self-managed training session: After the workshop, each team will have 20 minutes to self-train the introduction of the device in the complete OHCA management sequence on a CPR manikin permitting airway management. They will be supported by a demonstration video, which they could use freely. Resuscitation scenario: When entering the study room, an overview of the characteristics of the simulation manikin and the use of the defibrillator will be given through a standardized video. The team will then be asked to perform a 10-minutes highly realistic adult CPR scenario on a high-fidelity WiFi manikin. The procedure will be standardized across all sites to ensure that each participant is exposed to exactly the same case, with similar challenges in decision-making and treatment provided on the same manikin. The uniform delivery of the scenario throughout the entire study will minimize confounders. The room will be exclusively devoted to the simulation to prevent unexpected interruptions or external stimuli. The scenario will start with a clinical statement to recognize the life-threatening condition of the patient, given by one of the investigators as follows: " Here is Michael, a 50-years old who suddenly collapsed 10 minutes ago. He is now unconscious, pale and seems not breathing. The medical reinforcement is already underway and will be on site in about ten minutes. No first responder were dispatched to the scene and there is no bystander ". The team leader will be asked to reformulate this statement (closed-loop communication) to ensure comprehension. He will then open the following envelope of the stack. The opaque, sealed envelope will contain the approach they will have to apply: standard care or experimental approach. From this point on, there will be no more contact between the participants and the study team, except to stop the scenario. If the participant checks the breathing, the patient will be apneic and pulse will be absent if checked. The first compression will be defined as T0. After placement of the pads, the defibrillator's display will show ventricular fibrillation (VF). All following rhythm analyses will show refractory VF, regardless of whether a shock is delivered. To increase simulation's fidelity, CPR waves will be displayed when compressions will be delivered. Participants will be able to obtain an intravenous access on first attempt. They should administer first 1 mg of epinephrine (at the earliest after the second shock), then a first-dose of amiodarone or lidocaine following local protocols (in accordance with the 2020 AHA cardiac arrest algorithm. The scenario will be stopped exactly 10 minutes after the first compression. There will be no feedback after the study period.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Arrest, Cardiopulmonary Arrest, Emergency Medical Services, Resuscitation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Prospective, multicenter, randomized, controlled trial
Masking
ParticipantOutcomes Assessor
Masking Description
During pre-scenario sessions (device workshop and 20-minute self-training session) the teams will not have been allocated to one of the study paths. Allocation will be discovered as late as possible (after manikin's and defibrillatory characteristics presentation as well as the simulated patient's condition is given). From the moment of the allocation, it will be no more contact between investigators and participants. Due to the nature of the study with us of a supraglottic device, we are not able to blind participants, however they will be unaware of study outcomes. Assessment bias will be limited by using a high-fidelity manikin (SimMan 3G, Laerdal®, Stavanger, Norway) to collect study outcomes. Data analyst will be blinded to group allocation.
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
I-gel® group
Arm Type
Experimental
Arm Description
Continuous chest compressions from the start of the CPR with early i-gel® device insertion and asynchronous ventilations
Arm Title
Standard group
Arm Type
Other
Arm Description
Basic (standard) management by using a ratio of 30 compressions and 2 face mask ventilations
Intervention Type
Device
Intervention Name(s)
I-gel® supraglottic device
Intervention Description
Use of an i-gel® supraglottic device to deliver ventilations
Intervention Type
Device
Intervention Name(s)
Face mask ventilation
Intervention Description
Use of a face mask to deliver ventilations
Primary Outcome Measure Information:
Title
Chest compressions fraction (CCF) over the first 2 minutes of CPR
Description
Proportion of time where compressions are performed during the first two minutes of the scenario
Time Frame
At the end of Cycle 1 (each cycle is 2 minutes)
Secondary Outcome Measure Information:
Title
CCF of second cycle
Description
Proportion of time where compressions are performed during the following two minutes of the scenario
Time Frame
At the end of Cycle 2 (each cycle is 2 minutes)
Title
CCF of third cycle
Description
Proportion of time where compressions are performed during the following two minutes of the scenario
Time Frame
At the end of Cycle 3 (each cycle is 2 minutes)
Title
CCF of fourth cycle
Description
Proportion of time where compressions are performed during the following two minutes of the scenario
Time Frame
At the end of Cycle 4 (each cycle is 2 minutes)
Title
CCF of fifth cycle
Description
Proportion of time where compressions are performed during the following two minutes of the scenario
Time Frame
At the end of Cycle 5 (each cycle is 2 minutes)
Title
Overall CCF
Description
Proportion of time where compressions are performed during the entire scenario
Time Frame
10 minutes of scenario
Title
Chest compressions depth
Description
Mean depth of compressions
Time Frame
10 minutes of scenario
Title
Proportions of compressions above, below and in the depth target
Description
The depth target is 5 to 6 cm
Time Frame
10 minutes of scenario
Title
Chest compressions frequency
Description
Mean frequency of compressions
Time Frame
10 minutes of scenario
Title
Proportions of compressions above, below and in the frequency target
Description
The frequency target is 100 to 120 compressions by minute
Time Frame
10 minutes of scenario
Title
Time to first shock
Description
Interval between start of compressions and delivering of first shock
Time Frame
10 minutes of scenario
Title
Time to first effective ventilation
Description
Interval between start of compressions and delivering of first effective ventilation (defined as volume >300 ml)
Time Frame
10 minutes of scenario
Title
Ventilations volume
Description
Mean volume of ventilations
Time Frame
10 minutes of scenario
Title
Proportions of ventilations above, below and in the volume target
Description
The volume target is 300 to 700 ml
Time Frame
10 minutes of scenario
Title
User satisfaction assessed by a 5-point Likert scale ranging from "Not satisfied" to "Very satisfied"
Description
User satisfaction regarding applied approach assessed on a 5-point Likert scale ranging from "Not satisfied" to "Very satisfied"
Time Frame
10 minutes of scenario
Title
Self-assessed cognitive load using a 9-point scale ranging from "Very, very low mentale effort" to "Very, very high mental effort"
Description
Self-reported cognitive load during resuscitation scenario assessed using a 9-point symmetrical category scale which ranged from "Very, very low mental effort" (1) to "Very, very high mental effort" (9),
Time Frame
10 minutes of scenario
Title
Chest compression relaxation
Description
Proportion of correct compressions (with less than 5 mm deviation from reference value)
Time Frame
10 minutes of scenario
Title
Number of delivered ventilations
Description
Absolute number of delivered ventilations
Time Frame
10 minutes of scenario

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: To be a registered paramedic or EMT To have previously completed the 20-minute workshop on how using the device by on of the study investigators To have previously completed the 20-minute self-training session following a video recorded by the study investigators Participation agreement Exclusion Criteria: Member of the study investigators To have not undergone the 20-minute workshop To have not watch the video
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Loric Stuby
Organizational Affiliation
Genève TEAM Ambulances
Official's Role
Principal Investigator
Facility Information:
Facility Name
Genève TEAM Ambulances
City
Geneva
ZIP/Postal Code
1201
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All collected IPD will be deposited on Mendeley Data
IPD Sharing Time Frame
Starting 6 months after publication for at least two years
IPD Sharing Access Criteria
Open access on https://data.mendeley.com/
Citations:
PubMed Identifier
33804664
Citation
Stuby L, Jampen L, Sierro J, Paus E, Spichiger T, Suppan L, Thurre D. Effect on Chest Compression Fraction of Continuous Manual Compressions with Asynchronous Ventilations Using an i-gel(R) versus 30:2 Approach during Simulated Out-of-Hospital Cardiac Arrest: Protocol for a Manikin Multicenter Randomized Controlled Trial. Healthcare (Basel). 2021 Mar 20;9(3):354. doi: 10.3390/healthcare9030354.
Results Reference
background
PubMed Identifier
35011958
Citation
Stuby L, Jampen L, Sierro J, Bergeron M, Paus E, Spichiger T, Suppan L, Thurre D. Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial. J Clin Med. 2021 Dec 31;11(1):217. doi: 10.3390/jcm11010217.
Results Reference
result
PubMed Identifier
35455895
Citation
Stuby L, Suppan L, Jampen L, Thurre D. Impact of the Over-the-Head Position with a Supraglottic Airway Device on Chest Compression Depth and Rate: A Post Hoc Analysis of a Randomized Controlled Trial. Healthcare (Basel). 2022 Apr 13;10(4):718. doi: 10.3390/healthcare10040718.
Results Reference
result
Links:
URL
https://swiss-cpr-studies.ch/
Description
Whole project website

Learn more about this trial

Continuous Compressions With Asynchronous Ventilations Using I-gel Device Versus 30:2 Approach During Simulated OHCA

We'll reach out to this number within 24 hrs